Oxford Vaccine Trial
- All
- News
- Videos
-
Oxford Scientists Launch First Human Vaccine Trials For Nipah Virus
Nipah virus is carried by fruit bats and may also be transmitted by contact with infected animals or from person to person via close contact.
-
AstraZeneca Tests Booster Vaccine Against Beta Variant Of Covid
AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa.
-
Britain Seeks Extra AstraZeneca Shots To Combat "Beta" COVID-19 Variant
Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine that has been modified to better target the "beta" coronavirus variant first identified in South Africa, and it will fund trials of the shots.
-
AstraZeneca UK Vaccine Trial On Children Paused As Clot Link Probed
A British trial of the AstraZeneca coronavirus vaccine on children has been paused while regulators assess its possible link to blood clots, Oxford University, which helped develop the jab, said Tuesday.
-
Does World Need New Covid Vaccines? Oxford Vaccine Trial Chief Said This
It is not yet clear whether or not the world needs a new set of vaccines to fight different variants of the novel coronavirus but scientists are working on new ones so there is no reason for alarm, the head of the Oxford Vaccine Group said on Tuesday.
-
Extra Data Shows AstraZeneca Vaccine Efficacy In Elderly: UK Regulators
British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official said on Friday
-
In World First, Britain To Mix Pfizer And Oxford Vaccine Doses
British researchers are to explore mixing doses of the Pfizer and AstraZeneca COVID-19 vaccines in a world first trial aimed at finding new ways to swiftly reduce coronavirus infections as new mutated variants emerge.
-
Oxford To Run Trial Alternating COVID-19 Vaccines
Oxford University announced on Thursday it will launch a medical trial alternating doses of Covid-19 vaccines created by different manufacturers, the first study of its kind.
-
Oxford Vaccine Gives Good Immune Responses In Elderly, Says Trial Chief
The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford's vaccine trial chief Andrew Pollard said on Wednesday.
-
Oxford Kept UK Vaccine Volunteers In Dark On Dose Error: Report
About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.
-
South Africa To Pay $5.25 Per Dose For AstraZeneca Vaccine From India's SII
South Africa is hosting clinical trials of the vaccine developed by AstraZeneca in partnership with Oxford University, raising questions about the higher price it will be paying
-
Two Doses Of Oxford/AstraZeneca Vaccine Prompts Good Immune Response: Early Data Reveals
Data published earlier from later Phase 3 trials showed efficacy was 62 per cent for trial participants given two full doses
-
UK Medicine Regulator To Assess Best Dose For Oxford COVID-19 Vaccine
Britain's medical regulator will examine all the data from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator's chief executive said on Wednesday.
-
AstraZeneca-Oxford First To Publish Final-Stage Vaccine Trial Results
Oxford University and AstraZeneca on Tuesday became the first Covid-19 vaccine makers to publish final-stage clinical trial data in a scientific journal, clearing a key hurdle in the global race to produce safe and effective drugs for the coronavirus.
-
Pfizer, Oxford Vaccines To Be Tested Together In UK Combination Trials
Even as it begins the first Covid immunizations with a shot from Pfizer Inc., the U.K. plans to test it in combination with another vaccine from AstraZeneca Plc.
-
Oxford Scientists Launch First Human Vaccine Trials For Nipah Virus
Nipah virus is carried by fruit bats and may also be transmitted by contact with infected animals or from person to person via close contact.
-
AstraZeneca Tests Booster Vaccine Against Beta Variant Of Covid
AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa.
-
Britain Seeks Extra AstraZeneca Shots To Combat "Beta" COVID-19 Variant
Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine that has been modified to better target the "beta" coronavirus variant first identified in South Africa, and it will fund trials of the shots.
-
AstraZeneca UK Vaccine Trial On Children Paused As Clot Link Probed
A British trial of the AstraZeneca coronavirus vaccine on children has been paused while regulators assess its possible link to blood clots, Oxford University, which helped develop the jab, said Tuesday.
-
Does World Need New Covid Vaccines? Oxford Vaccine Trial Chief Said This
It is not yet clear whether or not the world needs a new set of vaccines to fight different variants of the novel coronavirus but scientists are working on new ones so there is no reason for alarm, the head of the Oxford Vaccine Group said on Tuesday.
-
Extra Data Shows AstraZeneca Vaccine Efficacy In Elderly: UK Regulators
British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official said on Friday
-
In World First, Britain To Mix Pfizer And Oxford Vaccine Doses
British researchers are to explore mixing doses of the Pfizer and AstraZeneca COVID-19 vaccines in a world first trial aimed at finding new ways to swiftly reduce coronavirus infections as new mutated variants emerge.
-
Oxford To Run Trial Alternating COVID-19 Vaccines
Oxford University announced on Thursday it will launch a medical trial alternating doses of Covid-19 vaccines created by different manufacturers, the first study of its kind.
-
Oxford Vaccine Gives Good Immune Responses In Elderly, Says Trial Chief
The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford's vaccine trial chief Andrew Pollard said on Wednesday.
-
Oxford Kept UK Vaccine Volunteers In Dark On Dose Error: Report
About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.
-
South Africa To Pay $5.25 Per Dose For AstraZeneca Vaccine From India's SII
South Africa is hosting clinical trials of the vaccine developed by AstraZeneca in partnership with Oxford University, raising questions about the higher price it will be paying
-
Two Doses Of Oxford/AstraZeneca Vaccine Prompts Good Immune Response: Early Data Reveals
Data published earlier from later Phase 3 trials showed efficacy was 62 per cent for trial participants given two full doses
-
UK Medicine Regulator To Assess Best Dose For Oxford COVID-19 Vaccine
Britain's medical regulator will examine all the data from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator's chief executive said on Wednesday.
-
AstraZeneca-Oxford First To Publish Final-Stage Vaccine Trial Results
Oxford University and AstraZeneca on Tuesday became the first Covid-19 vaccine makers to publish final-stage clinical trial data in a scientific journal, clearing a key hurdle in the global race to produce safe and effective drugs for the coronavirus.
-
Pfizer, Oxford Vaccines To Be Tested Together In UK Combination Trials
Even as it begins the first Covid immunizations with a shot from Pfizer Inc., the U.K. plans to test it in combination with another vaccine from AstraZeneca Plc.
